Current and future therapy for hereditary angioedema
Hereditary angioedema (HAE) is an autosomal dominant disease characterized by recurrent episodes of potentially life-threatening angioedema. Attacks of angioedema in HAE patients typically last 3 or more days, begin during childhood, and continue to occur throughout life. Tragically, patients with H...
| Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 114(2005), 1 vom: 10. Jan., Seite 10-6 |
|---|---|
| Auteur principal: | |
| Format: | Article |
| Langue: | English |
| Publié: |
2005
|
| Accès à la collection: | Clinical immunology (Orlando, Fla.) |
| Sujets: | Journal Article Research Support, U.S. Gov't, P.H.S. Review Anabolic Agents Antifibrinolytic Agents Bradykinin Receptor Antagonists Complement C1 Inactivator Proteins Complement C1 Inhibitor Protein Recombinant Proteins SERPING1 protein, human plus... |